Vitamin D Receptor Polymorphism and Cancer: An Update.

BACKGROUND Vitamin D mediates its action via vitamin D receptor (VDR) and is involved in a wide variety of biological processes including regulation of cell proliferation and differentiation in normal tissue and apoptosis, and cell adhesion in tumor cells. The study of genetic variations in VDR may elucidate the association of vitamin D levels, its metabolism, and VDR polymorphism with various diseases and cancer. The association of VDR polymorphism with cancer has been reported; however, the literature lacks critical analyses of the studies in last 3 years. MATERIALS AND METHODS A systematic search of PubMed database (2015 through mid-2017) was conducted to provide a comprehensive overview of this clinical arena. RESULTS Studies on the association of VDR polymorphisms FokI, BsmI, TaqI, and ApaI and cancer have suggested the involvement of VDR polymorphism in tumorigenesis. CONCLUSION The inconsistent results and lack of the studies in some cancer types warrant additional research.

[1]  J. Stanford,et al.  Vitamin D receptor gene polymorphisms and prostate cancer risk , 2004, The Prostate.

[2]  J. Reichrath,et al.  Vitamin D receptor (VDR) polymorphisms and skin cancer , 2011 .

[3]  Geoffrey S. Tobias,et al.  Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk , 2015, PloS one.

[4]  Lei Wang,et al.  Association of vitamin D receptor Fok I polymorphism with the risk of prostate cancer: a meta-analysis , 2016, Oncotarget.

[5]  C. Sui,et al.  The vitamin D receptor gene ApaI polymorphism is associated with increased risk of renal cell carcinoma in Chinese population , 2016, Scientific Reports.

[6]  F. Tinahones,et al.  The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  Y. H. Lee,et al.  Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: a meta-analysis. , 2015, Genetics and molecular research : GMR.

[8]  Lihua Song,et al.  Association between Vitamin D Receptor Gene Polymorphisms and Breast Cancer Risk: A Meta-Analysis of 39 Studies , 2014, PloS one.

[9]  Jianming Guo,et al.  Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysis , 2016, OncoTargets and therapy.

[10]  Teruhiko Yoshida,et al.  Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study , 2016, PloS one.

[11]  Yuan-yuan Mi,et al.  Updated analysis of vitamin D receptor gene FokI polymorphism and prostate cancer susceptibility , 2016, Archives of medical science : AMS.

[12]  D. Agrawal,et al.  1,25-dihydroxyvitamin D in the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma , 2013, Expert review of clinical immunology.

[13]  Evaluation of OPN Level and VDR Gene Polymorphism in Patients with Hepatocellular Carcinoma , 2016 .

[14]  S. Gandini,et al.  Vitamin D receptor polymorphisms and cancer. , 2014, Advances in experimental medicine and biology.

[15]  R. Abbasi,et al.  Association of vitamin D receptor gene polymorphisms with prostate cancer risk in the Pakistani population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[16]  J. Ryś,et al.  Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma , 2015, BioMed research international.

[17]  S. Gandini,et al.  Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[18]  M. Duffy,et al.  Vitamin D analogues: Potential use in cancer treatment. , 2017, Critical reviews in oncology/hematology.

[19]  Qi Liu,et al.  FokI Polymorphism of the Vitamin D Receptor Gene Is Associated with Susceptibility to Gastric Cancer: A Case-Control Study. , 2015, The Tohoku journal of experimental medicine.

[20]  L. Goulart,et al.  Association of vitamin D receptor variants with clinical parameters in prostate cancer , 2016, SpringerPlus.

[21]  A. Brooks-Wilson,et al.  Genetic variation in vitamin D-related genes and risk of breast cancer among women of European and East Asian descent , 2016, Tumor Biology.

[22]  J. Michael Gaziano,et al.  A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer , 2007, PLoS medicine.

[23]  D. Agrawal,et al.  Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine , 2016, Arthritis Research & Therapy.

[24]  Y. J. Chai,et al.  VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma , 2017, Endocrine connections.

[25]  M. Baker,et al.  Association of Some Polymorphisms in the VDR Gene, CYP17 Gene and SRD5A2 Gene and Prostate Cancer among Lebanese Men , 2017, Asian Pacific journal of cancer prevention : APJCP.

[26]  B. Copple,et al.  Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules. , 2016, Pharmacological research.

[27]  U. Hamann,et al.  Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study , 2015, PloS one.

[28]  A. Patiño-García,et al.  Analysis of Polymorphisms of the Vitamin D Receptor, Estrogen Receptor, and Collagen I&agr;1 Genes and Their Relationship With Height in Children With Bone Cancer , 2003, Journal of pediatric hematology/oncology.

[29]  Kewei Wang,et al.  Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis , 2016, BMC Cancer.

[30]  T. Khan,et al.  Vitamin D Receptor Cdx-2 Polymorphism and Premenopausal Breast Cancer Risk in Southern Pakistani Patients , 2015, PloS one.

[31]  C. Bozkurt,et al.  Vitamin D Receptor (VDR) Polymorphisms in Pediatric Patients Presenting With Hodgkin’s Lymphoma , 2017, Journal of pediatric hematology/oncology.

[32]  N. Forones,et al.  Genetic Polymorphisms of Vitamin D Receptor (VDR), CYP27B1 and CYP24A1 Genes and the Risk of Colorectal Cancer , 2017, The International journal of biological markers.

[33]  S. Neuhausen,et al.  Variants of the VDR gene and Risk of Colon Cancer (United States) , 2001, Cancer Causes & Control.

[34]  L. Murray,et al.  Markers of vitamin D exposure and oesophageal cancer risk: a systematic review and meta-analysis. , 2016 .

[35]  A. Neugut,et al.  Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk , 2014, Cancer Causes & Control.

[36]  Kaiyun Yang,et al.  Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk , 2016, International journal of molecular sciences.

[37]  Ji-Young Hwang,et al.  Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis. , 2015, Maturitas.

[38]  N. Hamdy,et al.  Vitamin D receptor gene polymorphism in Egyptian pediatric acute lymphoblastic leukemia correlation with BMD , 2016, Meta gene.

[39]  S. Chanock,et al.  Vitamin D Pathway Genes, Diet, and Risk of Renal Cell Carcinoma , 2009, International journal of endocrinology.

[40]  M. Ravindran,et al.  Vitamin D insufficiency among children with cancer in India , 2016, Indian Journal of Medical and Paediatric Oncology.

[41]  A. Sigurdson,et al.  Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. , 2013, Anticancer research.

[42]  F. Zlámal,et al.  Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours—a single institution pilot study , 2016, Tumor Biology.

[43]  D. Wilson,et al.  Systematic review and meta-analysis: Prevalence and possible causes of vitamin D deficiency and insufficiency in pediatric cancer patients. , 2016, Clinical nutrition.

[44]  Q. Jamal,et al.  Do VDR Gene Polymorphisms Contribute to Breast Cancer? , 2016, Asian Pacific journal of cancer prevention : APJCP.

[45]  Yao Lin,et al.  Genetic association of VDR polymorphisms and multiple myeloma susceptibility : a case control study , 2017 .

[46]  F. Shafie,et al.  Vitamin D and VDR gene polymorphism (FokI)(Taq1) inepithelial ovarian cancer in North of Iran , 2016 .

[47]  J. Chen,et al.  Association between vitamin D receptor gene BsmI polymorphism and susceptibility to prostate cancer , 2016 .

[48]  Noha Mohammed Ali Haikal,et al.  Bsm1 Gene polymorphism of the vitamin D receptor in breast cancer patients: influence of obesity and relevant drugs , 2016, Comparative Clinical Pathology.

[49]  M. Atoum,et al.  The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[50]  R. Halwani,et al.  Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population , 2016, PloS one.

[51]  R. Hegazi,et al.  Vitamin D status, receptor gene BsmI (A/G) polymorphism and breast cancer in a group of Egyptian females , 2017 .

[52]  Xuefeng Wan,et al.  Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies , 2015, BMC Genetics.

[53]  Elizabeth L. Barry,et al.  Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial , 2017, JAMA oncology.

[54]  T. Hartman,et al.  No Association Between Vitamin D Intake, VDR Polymorphisms, and Colorectal Cancer in a Population-Based Case–Control Study , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[55]  W. Krajewski,et al.  Vitamin D and urological cancers , 2016, Central European journal of urology.

[56]  A. Ji,et al.  Vitamin D Signaling Pathways Confer the Susceptibility of Esophageal Squamous Cell Carcinoma in a Northern Chinese Population , 2017, Nutrition and cancer.

[57]  P. Muti,et al.  Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas , 2015, PloS one.

[58]  Z. Dai,et al.  Association of Vitamin D Receptor Cdx-2 Polymorphism With Cancer Risk , 2015, Medicine.

[59]  E. Riboli,et al.  Original Contribution Circulating 25-Hydroxyvitamin D3 in Relation to Renal Cell Carcinoma Incidence and Survival in the EPIC Cohort , 2014 .

[60]  Tianxin Lin,et al.  Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis. , 2016, Nutrition.

[61]  Sang Min Park,et al.  Vitamin D Intake and Risk of Skin Cancer in US Women and Men , 2016, PloS one.

[62]  H. Campbell,et al.  The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis , 2017, British Journal of Cancer.

[63]  S. Edge,et al.  Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis , 2016, Clinical Cancer Research.

[64]  Amal M. H. Mackawy,et al.  Vitamin d deficiency and its association with thyroid disease. , 2013, International journal of health sciences.

[65]  Su-zhan Zhang,et al.  Vitamin D Receptor Polymorphism and Breast Cancer Risk , 2016, Medicine.

[66]  S. Halalkhor,et al.  Vitamin D Receptor Poly(A) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels: Association with Susceptibility to Breast Cancer , 2015, Journal of breast cancer.

[67]  Zhuangkai Liu,et al.  Menopausal status could modify breast cancer risk associated with the fokI polymorphism in vitamin D receptor gene : a meta-analysis , 2016 .

[68]  P. Jagodziński,et al.  Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations. , 2016, Oncology letters.

[69]  D. Gerova,et al.  Serum 25-hydroxy vitamin D levels in Bulgarian patients with prostate cancer: a pilot study. , 2015, Clinical laboratory.

[70]  I. Stanganelli,et al.  Vitamin D status and risk for malignant cutaneous melanoma: recent advances , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[71]  Dokyoon Kim,et al.  Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population. , 2014, Gene.

[72]  A. Banham,et al.  Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D , 2016, Endocrinology.